MGMT and glioblastoma: We found high correlations among measurements of tumoral size by the three methods, with pre-operative FLAIR-T2 hyper-intensity areas and volumes providing the optimal neuroimaging biomarker to predict OS in primary glioblastoma patients, together with age ≥ 65 years and MGMT methylation.